25
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Strain Dependent Rat iNOS Promoter Activity—Correlation to Identified WT1 Transcription Factor Binding Site

, , , &
Pages 167-175 | Received 07 Jan 2003, Published online: 07 Jul 2009

References

  • Mandrup-Poulsen, T. (1996) "The role of interleukin-1 in the pathogenesis of 1DDM", Diabetologia 39, 1005–1029.
  • Eizirik, D.L. and Darville, M.I. (2001) "beta-Cell apoptosis and defense mechanisms: lessons from type 1 diabetes", Diabetes 50, S64—S69.
  • Corbett, J., Wang, J., Sweetland, M., Lancaster, J. and McDaniel, M. (1992) "Interleukin 1 beta induces the formation of nitric oxide by beta-cells purified from rodent islets of Langerhans. Evidence for the beta-cell as a source and site of action of nitric oxide", JCI 90, 2384–2391.
  • Andersen, H.U., Joergensen, K.H., Egeberg, J., Mandrup-Poulsen, T. and Nerup, J. (1994) "Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans", Diabetes 43, 770–777.
  • Southern, C., Schulster, D. and Green, I. (1990) "Inhibition of insulin secretion by interleukin-1-beta and tumor necrosis factor-alpha via an L-argenine-dependent nitric oxide generating mechanism", FEBS Lett. 276, 42–44.
  • Corbett, J.A. and McDaniel, M.L. (1996) "The use of aminogua-nidine, a selective iNOS inhibitor, to evaluate the role of nitric oxide in the development of autoinunune diabetes", Methods (Orlando) 10, 21–30.
  • Welsh, M., Welsh, N., Bendtzen, K., Mares, J., Strandell, E., Oberg, C., et al. (1995) "Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice", Diabetologia 38, 153 —160.
  • Rabinovitch, A., Suarez-Pinzon, W.L., Sorensen, 0. and Bleackley, R.C. (1996) "Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets", Endocrinology 137, 2093–2099.
  • Reddy, S. and Young, M. (2002) "IL- lbeta expression in islet cells of the NOD mouse and its spatial relationship to beta cells and inducible nitric oxide synthase", Ann. N Y Acad. Sci. 958, 190–193.
  • Kleemann, R., Rothe, H., Bachofen, V.K., Xie, Q.W., Nathan, C., Martin, S., et al. (1993) "Transcription and translation of inducible nitric oxide in the pancreas of prediabetic BB rats", FEBS Lett. 328, 9–12.
  • Kolb, H., Worz-Pagenstert, U., Kleemann, R., Rothe, H., Rowsell, P. and Scott, F.W. (1996) "Cytokine gene expression in the BB rat pancreas: natural course and impact of bacterial vaccines", Diabetologia 39, 1448–1454.
  • Takamura, T., Kato, I., Kimura, N., Nakazawa, T., Yonekura, H., Takasawa, S., et al. (1998) "Transgenic mice overexpressing Type 2 nitric-oxide synthase in pancreatic beta-cells develop insulin-dependent diabetes without insulitis", J. Biol. Chem. 273, 2493–2496.
  • Liu, D., Pavlovic, D., Chen, M., Flodstrom, M., Sandler, S. and Eizirik, D. (2000) "Cytokines induce apoptosis in beta-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS — I—)", Diabetes 49, 1116–1122.
  • Andersson, AK., Flodström, M. and Sandler, S. (2001) "Cytokine-induced inhibition of insulin release from mouse pancreatic beta-cells deficient in inducible nitric oxide synthase", Biochem. Biophys. Res. Commun. 281, 396–403.
  • Eberhardt, W., Kunz, D., Hummel, R. and Pfeilschifter, J. (1996) "Molecular cloning of the rat inducible nitric oxide synthase gene promoter", Biochem. Biophys. Res. Commun. 223, 752–756.
  • Keinanen, R., Vartiainen, N. and Koistinaho, J. (1999) "Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene", Gene 234, 297–305.
  • Beck, K.F. and Sterzel, R.B. (1996) "Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells", FEBS Lett. 394, 263–267.
  • Zhang, H., Chen, X., Teng, X., Snead, C. and Catravas, J.D. (1998) "Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells", Biochem. Phannacol. 55, 1873–1880.
  • Spink, J. and Evans, T. (1997) "Binding of the transcription factor interferon regulatory factor-1 to the inducible nitric-oxide synthase promoter", J. Biol. Chem. 272, 24417–24425.
  • Xie, Q.W., Whisnant, R. and Nathan, C. (1993) "Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopoly-saccharide", J. Exp. Med. 177, 1779–1784.
  • Xie, Q.W., Kashiwabara, Y. and Nathan, C. (1994) "Role of transcription factor NF-KB/Rel in induction of nitric oxide synthase", J. Biol. Chem. 269, 4705–4708.
  • Kim, Y.M., Lee, B.S., Yi, KY. and Palk, S.G. (1997) "Upstream NF-kappaB site is required for the maximal expression of mouse inducible nitric oxide synthase gene in interferon-gamma plus lipopolysaccharide-induced RAW 264.7 macrophages", Biochem. Biophys. Res. Commun. 236, 655–660.
  • Lowenstein, C.J., Alley, E.W., Raval, P., Snowman, A.M., Snyder, S.H., Russell, S.W., et al. (1993) "Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide", Proc. Natl Acad. Sci. USA 90, 9730–9734.
  • Darville, M.I. and Eizirik, D.L. (1998) "Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin producing cells", Diabetologia 41, 1101–1108.
  • Sekiya, K., Nagasaki, H., Ozald, N., Suzuki, A., Miura, Y. and Oiso, Y. (2000) "Pituitary adenylate cyclase-activating polypeptide prevents cytokine-induced cytotmdcity via inhibition of inducible nitric oxide synthase expression in betaTC cells", Biochem. Biophys. Res. Commun. 278, 211–216.
  • Bellmann, K., Burkart, V., Bruckhoff, J., Kolb, H. and Landry, J. (2000) "p38-dependent enhancement of cytokine-induced nitric-oxide synthase gene expression by heat shock protein 70", J. Biol. Chem. 275, 18172–18179.
  • Karlsen, A.E., Ronn, S.G., Lindberg, K., Johannesen, J., Galsgaard, E.D., Pociot, F., et al. (2001) "Suppressor of cytokine signaling 3 (SOCS-3) protects beta-cells against interleukin-lbeta- and interferon-gamma-mediated toxicity", Proc. Nall Acad. Sci. USA 98, 12191–12196.
  • Liu, D., Darville, M. and Eizirik, D.L. (2001) "Double-stranded ribonucleic acid (RNA) induces beta-cell Fas messenger RNA expression and increases cytokine-induced beta-cell apoptosis", Endocrinology 142, 2593–2599.
  • Eizirik, D.L., Flodstroem, M., Karlsen, A.E. and Welch, N. (1996) "The harmony of the spheres: inducible nitric oxide and related genes in the pancreatic beta cells", Diabetologia 39, 875–890.
  • Johannesen, J., Pociot, F., Karlsen, A.E., Mandrup-Poulsen, T. and Nerup, J. (2001) "Strain-dependent difference in inducible nitric oxide synthesis (NOS) expression in rat pancreatic islets correlates with interferon regulating factor 1 (1RF-1) and heat shock protein 70 (H5P70) expression", Eur. Cytokine Netw. 12, 501–509.
  • Pociot, F., MOlvig, J., Wogensen, L., Worsaae, H., DalbOge, H., Baek, L., et al. (1991) "A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin- dependent diabetes mellitus", J. Scand. ImmunoL 33, 37–49.
  • Walker, C., Rutten, F., Yuan, X., Pass, H., Mew, D.M. and Everitt, J. (1994) "Wilms' tumor suppressor gene expression in rat and human mesothelioma", Cancer Res. 54, 3101–3106.
  • Bickmore, W.A., Oghene, K., Little, M.H., Seawright, A., van-Heyningen, V. and Hastie, N.D. (1992) "Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt 1 gene transcript", Science 257, 235–237.
  • Karlsen, A., Pavlovic, D., Nielsen, K., Jensen, J., Andersen, H., Pociot, F., et al. (2000) "Interferon-gamma induces interleukin-1 converting enzyme expression in pancreatic islets by an interferon regulatory factor- 1 -dependent mechanism", J. Clin. EndocrinoL Metab. 85, 830–836.
  • Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., et al. (2001) "Nitric oxide-induced apoptosis in pancreatic beta cells is mediated by the endoplasmic reticulum stress pathway", Proc. Nall Acad. Sci. USA 98, 10845–10850.
  • Xie, K.P., Huang, S.Y., Dong, Z.Y. and Fidler, I.J. (1993) "Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric-oxide", Int. J. OncoL 3, 1043–1048.
  • Reimers, J.I., Andersen, H.U., Mauricio, D., Pociot, F., Karlsen, A.E., Petersen, J.S., et al. (1996) "Strain-dependent differences in sensitivity of rat beta-cells to IL-lb in vitro and in vivo", Diabetes 45, 771–778.
  • Little, M., Holmes, G. and Walsh, P. (1999) "WT1: what has the last decade told us?", BioEssays 21, 191–202.
  • Menke, A.L., Shvarts, A., Riteco, N., van-Ham, R.C., van-der Eb, A.J. and Jochemsen, A.G. (1997) "Wilms' tumor 1-KTS isoforms induce p53-independent apoptosis that can be partially rescued by expression of the epidermal growth factor receptor or the insulin receptor", Cancer Res. 57, 1353–1363.
  • Hastie, N.D. (2001) "Life, sex, and WT1 isoforms—three amino acids can make all the difference", Cell 106, 391–394.
  • Coles, H.S., Burne, J.F. and Raff, M.C. (1993) "Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor", Development 118, 777–784.
  • Davies, R., Moore, A., Schedl, A., Bratt, E., Miyahawa, K., Ladomery, M., et al. (1999) "Multiple roles for the Wilms' tumor suppressor, WT1", Cancer Res. 59, 1747S–1750S.
  • Maheswaran, S., Englert, C., Bennett, P., Heinrich, G. and Haber, D.A. (1995) "The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis", Genes Dev. 9, 2143–2156.
  • Englert, C., Hou, X., Maheswaran, S., Bennett, P., Ngwu, C., Re, G.G., et al. (1995) "WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis", EMBO J. 14, 4662–4675.
  • Maheswaran, S., Park, S., Bernard, A., Morris, J.F., Rauscher, F.J., Hill, D.E., et al. (1993) "Physical and functional interaction between WT1 and p53 proteins", Proc. Nall Acad. Sci. USA 90, 5100–5104.
  • Reddy, J.C. and Licht, J.D. (1996) "The WT1 Wilms' tumor suppressor gene: how much do we really know?", Biochim. Biophys. Acta 1287, 1–28.
  • Hammes, A., Guo, J.K., Lutsch, G., Leheste, J.R., Landrock, D., Ziegler, U., et al. (2001) "Two splice variants of the Wilms' tumor 1 gene have distinct functions during sex determination and nephron formation", Cell 106, 319–329.
  • Thai, G., Iskandar, M., Barilla, K. and Romaniuk, P.J. (2001) "Characterization of RNA aptamer binding by the Wilms' tumor suppressor protein WT1", Biochemistry 40, 2032–2040.
  • Belin, V.D., Southern, C. and Green, LC. (2000) "Influence of the 3/UTR on IL- lbeta stimulation of an iNOS reporter system", Diabetologia 43, A122.
  • Forstermann, U., Gath, I., Schwarz, P., Closs, E.I. and Kleinert, H. (1995) "Isoforms of nitric-oxide synthase-properties, cellular-distribution and expressional control", Biochem. PhannacoL 50, 1321–1332.
  • Geller, D.A. and Billiar, T.R. (1998) "Molecular biology of nitric oxide synthases", Cancer Metastasis Rev. 17, 7–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.